SEC Form 4 · accession 0000899243-17-017103
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony B Evnin
Director
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.70 | Jun 21, 2017 | A | 20,000 | A | — | Jun 21, 2027 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (right to buy)F2 | $0.70 | Jun 21, 2017 | A | 57,857 | A | — | Jun 21, 2027 | Common Stock | 57,857 | 57,857 | D |
Explanation of responses
- F1This option vests in equal monthly installments from June 1, 2017 through June 1, 2018 subject to the Reporting Person's continued service to the company.
- F2This option vests in equal quarterly installments from June 1, 2017 through June 1, 2018 subject to the Reporting Person's continued service to the company.